Assessment of Federal Value-Based Incentive Programs and In-Hospital Clostridioides difficile Infection Rates
Health care facility-onset Clostridioides difficile infection (HO-CDI) rates reported to the US Centers for Disease Control and Prevention's National Healthcare Safety Network (NHSN) became a target quality metric for 2 Centers for Medicare & Medicaid Services (CMS) value-based incentive pr...
Gespeichert in:
| Veröffentlicht in: | JAMA network open 2021-10, Vol.4 (10), p.e2132114-e2132114 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e2132114 |
|---|---|
| container_issue | 10 |
| container_start_page | e2132114 |
| container_title | JAMA network open |
| container_volume | 4 |
| creator | Alrawashdeh, Mohammad Rhee, Chanu Hsu, Heather Wang, Rui Horan, Kelly Lee, Grace M |
| description | Health care facility-onset Clostridioides difficile infection (HO-CDI) rates reported to the US Centers for Disease Control and Prevention's National Healthcare Safety Network (NHSN) became a target quality metric for 2 Centers for Medicare & Medicaid Services (CMS) value-based incentive programs (VBIPs) in October 2016. The association of VBIPs with HO-CDI rates is unknown.
To examine the association between VBIP implementation and HO-CDI rates.
This interrupted time series study evaluated HO-CDI rates among adults hospitalized from January 2013 to March 2019 at 265 acute-care hospitals.
Implementation of VBIPs in October 2016.
Quarterly rates of HO-CDI per 10 000 patient-days, as reported to NHSN by participating hospitals, were evaluated. Generalized estimating equations were used to fit negative binomial regression models to estimate immediate program effect size (ie, level change) and changes in the slope of HO-CDI rates, controlling for each hospital's predominant method of CDI testing (ie, nucleic acid amplification test [NAAT], enzyme immunoassay [EIA] for toxin, or other testing methods).
The study cohort included 24 332 938 admissions, 109 371 136 patient-days, and 74 681 HO-CDI events at 265 hospitals (145 [55%] with 100-399 beds; 205 [77%] not-for-profit hospitals; 185 [70%] teaching hospitals; 229 [86%] in metropolitan areas). Compared with EIA, rates of HO-CDI were higher when detected by NAAT (adjusted incidence rate ratio [aIRR], 1.55; 95% CI, 1.40-1.70; P |
| doi_str_mv | 10.1001/jamanetworkopen.2021.32114 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8556622</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2668862107</sourcerecordid><originalsourceid>FETCH-LOGICAL-a473t-2d063aa074442d4cdc837b40e0c72df7000b142d49532f709530fd1d33ebc8743</originalsourceid><addsrcrecordid>eNpdkVtP3DAQha2qVUGUv4Ai-tKXbMeXxNk-VKIrbhJSqwp4tbz2BLxN4q0noeLf4xSKKE9je745muPD2CGHBQfgnze2twOOf2L6Fbc4LAQIvpCCc_WG7YpKq1I2UL19cd5h-0QbABDA5bKu3rMdqTRXUta7rD8iQqIeh7GIbXGCHpPtimvbTVh-s4S-OB9c7oY7LH6keJNsT4Ud5ufyLNI2jBlfdZHGFHyIwSMVPrRtcKHDDLXoxhCH4qcdkT6wd63tCPef6h67Ojm-XJ2VF99Pz1dHF6VVWo6l8FBLa0ErpYRXzrtG6rUCBKeFb3X2suZzZ1lJka-5QOu5lxLXrtFK7rGvj7rbad2jn_fPrsw2hd6mexNtMP93hnBrbuKdaaqqroXIAp-eBFL8PSGNpg_ksOvy38eJjKiWwAWHqsnox1foJk5pyPaMqOumqTOmM_XlkXIpEiVsn5fhYOZgzatgzRys-RtsHj54aed59F-M8gGrLKUm</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2668862107</pqid></control><display><type>article</type><title>Assessment of Federal Value-Based Incentive Programs and In-Hospital Clostridioides difficile Infection Rates</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Alrawashdeh, Mohammad ; Rhee, Chanu ; Hsu, Heather ; Wang, Rui ; Horan, Kelly ; Lee, Grace M</creator><creatorcontrib>Alrawashdeh, Mohammad ; Rhee, Chanu ; Hsu, Heather ; Wang, Rui ; Horan, Kelly ; Lee, Grace M</creatorcontrib><description>Health care facility-onset Clostridioides difficile infection (HO-CDI) rates reported to the US Centers for Disease Control and Prevention's National Healthcare Safety Network (NHSN) became a target quality metric for 2 Centers for Medicare & Medicaid Services (CMS) value-based incentive programs (VBIPs) in October 2016. The association of VBIPs with HO-CDI rates is unknown.
To examine the association between VBIP implementation and HO-CDI rates.
This interrupted time series study evaluated HO-CDI rates among adults hospitalized from January 2013 to March 2019 at 265 acute-care hospitals.
Implementation of VBIPs in October 2016.
Quarterly rates of HO-CDI per 10 000 patient-days, as reported to NHSN by participating hospitals, were evaluated. Generalized estimating equations were used to fit negative binomial regression models to estimate immediate program effect size (ie, level change) and changes in the slope of HO-CDI rates, controlling for each hospital's predominant method of CDI testing (ie, nucleic acid amplification test [NAAT], enzyme immunoassay [EIA] for toxin, or other testing methods).
The study cohort included 24 332 938 admissions, 109 371 136 patient-days, and 74 681 HO-CDI events at 265 hospitals (145 [55%] with 100-399 beds; 205 [77%] not-for-profit hospitals; 185 [70%] teaching hospitals; 229 [86%] in metropolitan areas). Compared with EIA, rates of HO-CDI were higher when detected by NAAT (adjusted incidence rate ratio [aIRR], 1.55; 95% CI, 1.40-1.70; P < .001) and other testing methods (aIRR, 1.47; 95% CI, 1.26-1.71; P < .001). There were no significant changes in testing methods used by hospitals immediately after VBIP implementation. Controlling for CDI testing method, VBIP implementation was associated with a 6% level decline in HO-CDI rates in the immediate postpolicy quarter (aIRR, 0.94; 95% CI, 0.89-0.99; P = .01) and a 4% decline in slope per quarter (aIRR, 0.96; 95% CI, 0.95-0.97; P < .001). Results were similar in a sensitivity analysis using a 1-year roll-in period accounting for the period after the announcement of the HO-CDI VBIP policy and prior to its implementation.
In this study, VBIP implementation was associated with improvements in HO-CDI rates, independent of CDI testing method. Given that CMS payment policies have not previously been associated with improvements in other targeted health care-associated infection rates, future research should focus on elucidating the specific processes that contributed to improvement in HO-CDI rates to inform the design of future VBIP interventions.</description><identifier>ISSN: 2574-3805</identifier><identifier>EISSN: 2574-3805</identifier><identifier>DOI: 10.1001/jamanetworkopen.2021.32114</identifier><identifier>PMID: 34714336</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Clostridium Infections - epidemiology ; Clostridium Infections - prevention & control ; Cross Infection - epidemiology ; Humans ; Incidence ; Infectious Diseases ; Motivation ; Online Only ; Original Investigation ; Quality Assurance, Health Care - economics ; Southeastern United States - epidemiology</subject><ispartof>JAMA network open, 2021-10, Vol.4 (10), p.e2132114-e2132114</ispartof><rights>2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright 2021 Alrawashdeh M et al. .</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a473t-2d063aa074442d4cdc837b40e0c72df7000b142d49532f709530fd1d33ebc8743</citedby><cites>FETCH-LOGICAL-a473t-2d063aa074442d4cdc837b40e0c72df7000b142d49532f709530fd1d33ebc8743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,860,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34714336$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alrawashdeh, Mohammad</creatorcontrib><creatorcontrib>Rhee, Chanu</creatorcontrib><creatorcontrib>Hsu, Heather</creatorcontrib><creatorcontrib>Wang, Rui</creatorcontrib><creatorcontrib>Horan, Kelly</creatorcontrib><creatorcontrib>Lee, Grace M</creatorcontrib><title>Assessment of Federal Value-Based Incentive Programs and In-Hospital Clostridioides difficile Infection Rates</title><title>JAMA network open</title><addtitle>JAMA Netw Open</addtitle><description>Health care facility-onset Clostridioides difficile infection (HO-CDI) rates reported to the US Centers for Disease Control and Prevention's National Healthcare Safety Network (NHSN) became a target quality metric for 2 Centers for Medicare & Medicaid Services (CMS) value-based incentive programs (VBIPs) in October 2016. The association of VBIPs with HO-CDI rates is unknown.
To examine the association between VBIP implementation and HO-CDI rates.
This interrupted time series study evaluated HO-CDI rates among adults hospitalized from January 2013 to March 2019 at 265 acute-care hospitals.
Implementation of VBIPs in October 2016.
Quarterly rates of HO-CDI per 10 000 patient-days, as reported to NHSN by participating hospitals, were evaluated. Generalized estimating equations were used to fit negative binomial regression models to estimate immediate program effect size (ie, level change) and changes in the slope of HO-CDI rates, controlling for each hospital's predominant method of CDI testing (ie, nucleic acid amplification test [NAAT], enzyme immunoassay [EIA] for toxin, or other testing methods).
The study cohort included 24 332 938 admissions, 109 371 136 patient-days, and 74 681 HO-CDI events at 265 hospitals (145 [55%] with 100-399 beds; 205 [77%] not-for-profit hospitals; 185 [70%] teaching hospitals; 229 [86%] in metropolitan areas). Compared with EIA, rates of HO-CDI were higher when detected by NAAT (adjusted incidence rate ratio [aIRR], 1.55; 95% CI, 1.40-1.70; P < .001) and other testing methods (aIRR, 1.47; 95% CI, 1.26-1.71; P < .001). There were no significant changes in testing methods used by hospitals immediately after VBIP implementation. Controlling for CDI testing method, VBIP implementation was associated with a 6% level decline in HO-CDI rates in the immediate postpolicy quarter (aIRR, 0.94; 95% CI, 0.89-0.99; P = .01) and a 4% decline in slope per quarter (aIRR, 0.96; 95% CI, 0.95-0.97; P < .001). Results were similar in a sensitivity analysis using a 1-year roll-in period accounting for the period after the announcement of the HO-CDI VBIP policy and prior to its implementation.
In this study, VBIP implementation was associated with improvements in HO-CDI rates, independent of CDI testing method. Given that CMS payment policies have not previously been associated with improvements in other targeted health care-associated infection rates, future research should focus on elucidating the specific processes that contributed to improvement in HO-CDI rates to inform the design of future VBIP interventions.</description><subject>Clostridium Infections - epidemiology</subject><subject>Clostridium Infections - prevention & control</subject><subject>Cross Infection - epidemiology</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infectious Diseases</subject><subject>Motivation</subject><subject>Online Only</subject><subject>Original Investigation</subject><subject>Quality Assurance, Health Care - economics</subject><subject>Southeastern United States - epidemiology</subject><issn>2574-3805</issn><issn>2574-3805</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkVtP3DAQha2qVUGUv4Ai-tKXbMeXxNk-VKIrbhJSqwp4tbz2BLxN4q0noeLf4xSKKE9je745muPD2CGHBQfgnze2twOOf2L6Fbc4LAQIvpCCc_WG7YpKq1I2UL19cd5h-0QbABDA5bKu3rMdqTRXUta7rD8iQqIeh7GIbXGCHpPtimvbTVh-s4S-OB9c7oY7LH6keJNsT4Ud5ufyLNI2jBlfdZHGFHyIwSMVPrRtcKHDDLXoxhCH4qcdkT6wd63tCPef6h67Ojm-XJ2VF99Pz1dHF6VVWo6l8FBLa0ErpYRXzrtG6rUCBKeFb3X2suZzZ1lJka-5QOu5lxLXrtFK7rGvj7rbad2jn_fPrsw2hd6mexNtMP93hnBrbuKdaaqqroXIAp-eBFL8PSGNpg_ksOvy38eJjKiWwAWHqsnox1foJk5pyPaMqOumqTOmM_XlkXIpEiVsn5fhYOZgzatgzRys-RtsHj54aed59F-M8gGrLKUm</recordid><startdate>20211001</startdate><enddate>20211001</enddate><creator>Alrawashdeh, Mohammad</creator><creator>Rhee, Chanu</creator><creator>Hsu, Heather</creator><creator>Wang, Rui</creator><creator>Horan, Kelly</creator><creator>Lee, Grace M</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20211001</creationdate><title>Assessment of Federal Value-Based Incentive Programs and In-Hospital Clostridioides difficile Infection Rates</title><author>Alrawashdeh, Mohammad ; Rhee, Chanu ; Hsu, Heather ; Wang, Rui ; Horan, Kelly ; Lee, Grace M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a473t-2d063aa074442d4cdc837b40e0c72df7000b142d49532f709530fd1d33ebc8743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Clostridium Infections - epidemiology</topic><topic>Clostridium Infections - prevention & control</topic><topic>Cross Infection - epidemiology</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infectious Diseases</topic><topic>Motivation</topic><topic>Online Only</topic><topic>Original Investigation</topic><topic>Quality Assurance, Health Care - economics</topic><topic>Southeastern United States - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alrawashdeh, Mohammad</creatorcontrib><creatorcontrib>Rhee, Chanu</creatorcontrib><creatorcontrib>Hsu, Heather</creatorcontrib><creatorcontrib>Wang, Rui</creatorcontrib><creatorcontrib>Horan, Kelly</creatorcontrib><creatorcontrib>Lee, Grace M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>JAMA network open</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alrawashdeh, Mohammad</au><au>Rhee, Chanu</au><au>Hsu, Heather</au><au>Wang, Rui</au><au>Horan, Kelly</au><au>Lee, Grace M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessment of Federal Value-Based Incentive Programs and In-Hospital Clostridioides difficile Infection Rates</atitle><jtitle>JAMA network open</jtitle><addtitle>JAMA Netw Open</addtitle><date>2021-10-01</date><risdate>2021</risdate><volume>4</volume><issue>10</issue><spage>e2132114</spage><epage>e2132114</epage><pages>e2132114-e2132114</pages><issn>2574-3805</issn><eissn>2574-3805</eissn><abstract>Health care facility-onset Clostridioides difficile infection (HO-CDI) rates reported to the US Centers for Disease Control and Prevention's National Healthcare Safety Network (NHSN) became a target quality metric for 2 Centers for Medicare & Medicaid Services (CMS) value-based incentive programs (VBIPs) in October 2016. The association of VBIPs with HO-CDI rates is unknown.
To examine the association between VBIP implementation and HO-CDI rates.
This interrupted time series study evaluated HO-CDI rates among adults hospitalized from January 2013 to March 2019 at 265 acute-care hospitals.
Implementation of VBIPs in October 2016.
Quarterly rates of HO-CDI per 10 000 patient-days, as reported to NHSN by participating hospitals, were evaluated. Generalized estimating equations were used to fit negative binomial regression models to estimate immediate program effect size (ie, level change) and changes in the slope of HO-CDI rates, controlling for each hospital's predominant method of CDI testing (ie, nucleic acid amplification test [NAAT], enzyme immunoassay [EIA] for toxin, or other testing methods).
The study cohort included 24 332 938 admissions, 109 371 136 patient-days, and 74 681 HO-CDI events at 265 hospitals (145 [55%] with 100-399 beds; 205 [77%] not-for-profit hospitals; 185 [70%] teaching hospitals; 229 [86%] in metropolitan areas). Compared with EIA, rates of HO-CDI were higher when detected by NAAT (adjusted incidence rate ratio [aIRR], 1.55; 95% CI, 1.40-1.70; P < .001) and other testing methods (aIRR, 1.47; 95% CI, 1.26-1.71; P < .001). There were no significant changes in testing methods used by hospitals immediately after VBIP implementation. Controlling for CDI testing method, VBIP implementation was associated with a 6% level decline in HO-CDI rates in the immediate postpolicy quarter (aIRR, 0.94; 95% CI, 0.89-0.99; P = .01) and a 4% decline in slope per quarter (aIRR, 0.96; 95% CI, 0.95-0.97; P < .001). Results were similar in a sensitivity analysis using a 1-year roll-in period accounting for the period after the announcement of the HO-CDI VBIP policy and prior to its implementation.
In this study, VBIP implementation was associated with improvements in HO-CDI rates, independent of CDI testing method. Given that CMS payment policies have not previously been associated with improvements in other targeted health care-associated infection rates, future research should focus on elucidating the specific processes that contributed to improvement in HO-CDI rates to inform the design of future VBIP interventions.</abstract><cop>United States</cop><pub>American Medical Association</pub><pmid>34714336</pmid><doi>10.1001/jamanetworkopen.2021.32114</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2574-3805 |
| ispartof | JAMA network open, 2021-10, Vol.4 (10), p.e2132114-e2132114 |
| issn | 2574-3805 2574-3805 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8556622 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Clostridium Infections - epidemiology Clostridium Infections - prevention & control Cross Infection - epidemiology Humans Incidence Infectious Diseases Motivation Online Only Original Investigation Quality Assurance, Health Care - economics Southeastern United States - epidemiology |
| title | Assessment of Federal Value-Based Incentive Programs and In-Hospital Clostridioides difficile Infection Rates |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T22%3A50%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessment%20of%20Federal%20Value-Based%20Incentive%20Programs%20and%20In-Hospital%20Clostridioides%20difficile%20Infection%20Rates&rft.jtitle=JAMA%20network%20open&rft.au=Alrawashdeh,%20Mohammad&rft.date=2021-10-01&rft.volume=4&rft.issue=10&rft.spage=e2132114&rft.epage=e2132114&rft.pages=e2132114-e2132114&rft.issn=2574-3805&rft.eissn=2574-3805&rft_id=info:doi/10.1001/jamanetworkopen.2021.32114&rft_dat=%3Cproquest_pubme%3E2668862107%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2668862107&rft_id=info:pmid/34714336&rfr_iscdi=true |